Home > Cashflow Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Cashflow Statement

BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹2.02 Cr₹57 Cr₹55 Cr₹44 Cr₹8.79 Cr
Adjustment ₹-1.14 Cr₹8.03 Cr₹1.18 Cr₹-0.59 Cr₹0.03 Cr
Changes In working Capital ₹11 Cr₹-47 Cr₹-16 Cr₹-41 Cr₹-22 Cr
Cash Flow after changes in Working Capital ₹12 Cr₹18 Cr₹40 Cr₹2.60 Cr₹-13 Cr
Cash Flow from Operating Activities ₹4.87 Cr₹6.08 Cr₹34 Cr₹0.00 Cr₹-14 Cr
Cash Flow from Investing Activities ₹-1.05 Cr₹-11 Cr₹-28 Cr₹-5.97 Cr₹-0.18 Cr
Cash Flow from Financing Activities ₹30 Cr₹26 Cr₹-0.16 Cr₹3.65 Cr₹18 Cr
Net Cash Inflow / Outflow ₹34 Cr₹21 Cr₹5.53 Cr₹-2.32 Cr₹3.88 Cr
Opening Cash & Cash Equivalents ₹28 Cr₹7.19 Cr₹1.66 Cr₹3.98 Cr₹0.10 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹62 Cr₹28 Cr₹7.19 Cr₹1.66 Cr₹3.98 Cr

Compare Cashflow Statement of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹302.8 Cr 4.8% 4.9% -46.9% Stock Analytics
ADANI ENTERPRISES ₹298,004.0 Cr 4.5% 14.7% -13.8% Stock Analytics
REDINGTON ₹22,354.8 Cr 6.3% 10% 43.5% Stock Analytics
MMTC ₹11,065.5 Cr -4.3% 41% 8.8% Stock Analytics
HONASA CONSUMER ₹10,492.0 Cr 3.3% 31.2% -23.1% Stock Analytics
LLOYDS ENTERPRISES ₹8,945.6 Cr 13.6% 48.2% 122.4% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

4.8%

4.9%

-46.9%

SENSEX

1.3%

2.6%

7.8%


You may also like the below Video Courses